MILLENNIUM MANAGEMENT LLC

Position in DMAC — DiaMedica Therapeutics Inc.

CIK 1273087 NEW YORK, NY

Position in DMAC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,950,975

-$382,982 QoQ

Shares Held

845,309

-9.6% QoQ

Ownership

1.57%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 87 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. DMAC ranks #155 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,950,975	845,309	-9.6%	Shares	Sole	2026-08-14
2026-03-31	$6,333,957	935,592	+21.7%	Shares	Sole	2026-05-15
2025-12-31	$6,117,737	768,560	-35.3%	Shares	Sole	2026-02-17
2025-09-30	$8,156,812	1,187,309	+252.4%	Shares	Sole	2025-11-14
2025-03-31	$1,276,775	336,880	+297.1%	Shares	Sole	2025-05-15
2024-12-31	$460,621	84,829	+151.8%	Shares	Sole	2025-02-14
2024-09-30	$141,161	33,690	+16.8%	Shares	Sole	2024-11-14
2023-12-31	$81,919	28,845	+0.6%	Shares	Sole	2024-02-14
2023-09-30	$73,973	28,672	+28.9%	Shares	Sole	2023-11-14
2021-12-31	$82,988	22,249	+7.5%	Shares	Sole	2022-02-14
2021-06-30	$92,070	20,690	-70.6%	Shares	Sole	2021-08-16
2021-03-31	$643,071	70,281	+72.0%	Shares	Sole	2021-05-17
2020-12-31	$414,330	40,861	+275.8%	Shares	Sole	2021-02-16
2020-03-31	$30,441	10,872	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.